Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle M Zerr

Showing results (141-150 of 146) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 146 results.
MMWR. Morbidity and Mortality Weekly Report|December 5, 2025
Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025Laura D Zambrano, Regina M Simeone, Margaret M Newhams, et al.
MMWR. Morbidity and Mortality Weekly Report|March 12, 2026
Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026Patrick Maloney, Emily L Reeves, Kristina Wielgosz, et al.
JAMA Network Open|August 15, 2023
Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal PeakNatasha Halasa, Laura D Zambrano, Justin Z Amarin, et al.
The Journal of Infectious Diseases|January 15, 2025
Assessing Clinical Improvement of Infants Hospitalized for Respiratory Syncytial Virus-Related Critical IllnessShannon B Leland, Laura D Zambrano, Steven J Staffa, et al.
MMWR. Morbidity and Mortality Weekly Report|April 18, 2024
Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023Laura D Zambrano, Margaret M Newhams, Regina M Simeone, et al.
MMWR. Morbidity and Mortality Weekly Report|November 14, 2024
Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024Aaron M Frutos, Haris M Ahmad, Dawud Ujamaa, et al.
Pageof 15

Showing results (141-150 of 146) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 146 results.
MMWR. Morbidity and Mortality Weekly Report|December 5, 2025
Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025Laura D Zambrano, Regina M Simeone, Margaret M Newhams, et al.
MMWR. Morbidity and Mortality Weekly Report|March 12, 2026
Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectiveness - United States, September 2025-February 2026Patrick Maloney, Emily L Reeves, Kristina Wielgosz, et al.
JAMA Network Open|August 15, 2023
Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal PeakNatasha Halasa, Laura D Zambrano, Justin Z Amarin, et al.
The Journal of Infectious Diseases|January 15, 2025
Assessing Clinical Improvement of Infants Hospitalized for Respiratory Syncytial Virus-Related Critical IllnessShannon B Leland, Laura D Zambrano, Steven J Staffa, et al.
MMWR. Morbidity and Mortality Weekly Report|April 18, 2024
Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023Laura D Zambrano, Margaret M Newhams, Regina M Simeone, et al.
MMWR. Morbidity and Mortality Weekly Report|November 14, 2024
Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024Aaron M Frutos, Haris M Ahmad, Dawud Ujamaa, et al.
Pageof 15